1. Home
  2. TNFA vs OCTO Comparison

TNFA vs OCTO Comparison

Compare TNFA & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNFA
  • OCTO
  • Stock Information
  • Founded
  • TNFA 2014
  • OCTO 1966
  • Country
  • TNFA United States
  • OCTO United States
  • Employees
  • TNFA N/A
  • OCTO N/A
  • Industry
  • TNFA
  • OCTO
  • Sector
  • TNFA
  • OCTO
  • Exchange
  • TNFA NYSE
  • OCTO Nasdaq
  • Market Cap
  • TNFA 3.2M
  • OCTO 3.8M
  • IPO Year
  • TNFA N/A
  • OCTO N/A
  • Fundamental
  • Price
  • TNFA $0.48
  • OCTO $1.72
  • Analyst Decision
  • TNFA
  • OCTO
  • Analyst Count
  • TNFA 0
  • OCTO 0
  • Target Price
  • TNFA N/A
  • OCTO N/A
  • AVG Volume (30 Days)
  • TNFA 852.2K
  • OCTO 37.2K
  • Earning Date
  • TNFA 03-31-2025
  • OCTO 04-01-2025
  • Dividend Yield
  • TNFA N/A
  • OCTO N/A
  • EPS Growth
  • TNFA N/A
  • OCTO N/A
  • EPS
  • TNFA N/A
  • OCTO N/A
  • Revenue
  • TNFA N/A
  • OCTO $39,835,256.00
  • Revenue This Year
  • TNFA N/A
  • OCTO N/A
  • Revenue Next Year
  • TNFA N/A
  • OCTO N/A
  • P/E Ratio
  • TNFA N/A
  • OCTO N/A
  • Revenue Growth
  • TNFA N/A
  • OCTO N/A
  • 52 Week Low
  • TNFA $0.45
  • OCTO $1.26
  • 52 Week High
  • TNFA $3.60
  • OCTO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • TNFA 26.35
  • OCTO 50.27
  • Support Level
  • TNFA $0.45
  • OCTO $1.68
  • Resistance Level
  • TNFA $0.66
  • OCTO $1.94
  • Average True Range (ATR)
  • TNFA 0.09
  • OCTO 0.15
  • MACD
  • TNFA -0.00
  • OCTO 0.01
  • Stochastic Oscillator
  • TNFA 7.07
  • OCTO 50.94

About TNFA TNF PHARMACEUTICALS INC EFFEC

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.

About OCTO Eightco Holdings Inc.

Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.

Share on Social Networks: